Health News Archive - April 24, 2009
If a student feels the path to college is closed, he or she may conclude that studying and homework are a waste of time, U.S.
VEENENDAAL, The Netherlands, April 24 /PRNewswire/ -- - Strong Product Offerings and Leadership in Brachytherapy Contribute to All-Time High Nucletron, a global leader in radiation oncology, today announced strong financial results in 2008 with net sales of EUR112.4 million (US $165 million).
OXFORD, England, April 24 /PRNewswire/ -- PharmaVentures Ltd, announced today that it has been engaged by Merck & Co, Inc. to advise and assist in divesting its world class research centre, the IRBM, located near Rome, Italy.
DENVER, April 24 /PRNewswire/ -- Pharmatech Oncology, Inc., a Research Management Organization (RMO) headquartered in Denver, Colorado, announces the launch of their Data Management business unit to the bioscience and pharmaceutical industries.
SILVER SPRING, Md., April 24 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will release its 2009 first quarter financial results before market open on Friday, May 1, 2009. United Therapeutics will host a half-hour teleconference on Friday, May 1, 2009, at 9:00 a.m.
Scientists at the University of South Dakota have invented a new germ-killing molecule that may soon enable the paint on your walls to kill bacteria, viruses, mold and other harmful organisms.
--Major Actions Implemented During 2008 Position the Company for Future Growth-- TSX Venture Exchange: NVC VANCOUVER, April 24 /PRNewswire-FirstCall/ - Neovasc Inc.
SEATTLE, April 24 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced the following data presentations taking place at the American Urological Association's (AUA) Annual Meeting in Chicago, as well as a Dendreon-sponsored IMPACT data webcast conference call: April 28, 2009, 2:20 p.m.
- Proceeds Will Advance Key New Products Including Completing CE Mark Application for the Reducer(TM) Stent for Refractory Angina - TSX Venture Exchange: NVC VANCOUVER, April 24 /PRNewswire-FirstCall/ - Neovasc Inc.
A surprising 66 percent drop in the death rate as a result of malaria has been witnessed in Zambia since the year 2000, making the country a leader in treatment for Africans, the World Health Organization reported on Thursday.